首页|Post-endoscopic retrograde cholangio-pancreatography pancreatitis: Is time for a new preventive approach?
Post-endoscopic retrograde cholangio-pancreatography pancreatitis: Is time for a new preventive approach?
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NETL
NSTL
万方数据
维普
Acute pancreatitis is the most common serious complication of endoscopic retrograde cholangio-pancreatography (ERCP) and its incidence may exceed 25％ in some high-risk patient subsets.In some patients,pancreatitis may follow a severe course with pancreatic necrosis,multiorgan failure,permanent disability and even death.Hence,approaches which minimize both the incidence and severity of post-ERCP pancreatitis are worth pursuing.Pancreatic stents have been used with some success in the prevention of post-ERCP,while so far pharmacological trials have yielded disappointing results.A recent multicenter,randomized,placebocontrolled,double-blind trial has shown that rectally administered indomethacin is effective in reducing the incidence of post-ERCP pancreatitis,the occurrence of episodes of moderate-to-severe pancreatitis and the length of hospital stay in high-risk patients.These results together with the demonstration that rectal administration of indomethacin is not associated with enhanced risk of bleeding strongly support the use of this drug in the prophylaxis of post-ERCP pancreatitis.
NETL
NSTL
万方数据
维普
